Literature DB >> 17034319

Pilot study for assessing the behaviors of patients with schizophrenia towards a virtual avatar.

Jeonghun Ku1, Hee Jeong Jang, Kwang Uk Kim, Sung Hyouk Park, Jae Jin Kim, Chan Hyung Kim, Sang Won Nam, In Young Kim, Sun I Kim.   

Abstract

This study examined whether a virtual avatar could be perceived as a real human by patients with mental disease, especially schizophrenia, as well as whether a virtual avatar could be applied to acquiring patients' behavior characteristics in a short conversation situation. The virtual avatar has been used for various applications which need to communicate with other person or to train or educate by showing humanlike behavior. Recently, many researches have shown that the virtual avatar technology has been enhanced and the avatar could be perceived like real human. A virtual avatar, standing in a virtual room, was designed for this study. Tasks to approach, initiate a talk, and answer to avatar's questions was assigned to the 11 patients with schizophrenia. As behavioral parameters in the virtual environment, the interpersonal distance and the verbal response time were acquired. In addition, the Positive and Negative Syndrome Scale (PANSS) for patients was administered in order to investigate the relationship between patients' symptomatic characteristics and behavior parameters. The interpersonal distance was negatively correlated with the negative syndrome scale, a subscale of PANSS, which is consistent with previous research reporting the relationship between interpersonal distance and a real person's image. The verbal response time, however, was not correlated with any other subscale of PANSS. After analyzing subitems of the negative syndrome of PANSS, two positive correlations were found: one was with blunted affect and the other was with poor rapport. We concluded that the virtual avatar could be perceived as a real human by schizophrenic patients and the avatar could draw the schizophrenic patients' behavior characteristics.

Entities:  

Mesh:

Year:  2006        PMID: 17034319     DOI: 10.1089/cpb.2006.9.531

Source DB:  PubMed          Journal:  Cyberpsychol Behav        ISSN: 1094-9313


  6 in total

1.  Social pressure-induced craving in patients with alcohol dependence: application of virtual reality to coping skill training.

Authors:  Jung Suk Lee; Kee Namkoong; Jeonghun Ku; Sangwoo Cho; Ji Yeon Park; You Kyong Choi; Jae-Jin Kim; In Young Kim; Sun I Kim; Young-Chul Jung
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

2.  Controlling social stress in virtual reality environments.

Authors:  Dwi Hartanto; Isabel L Kampmann; Nexhmedin Morina; Paul G M Emmelkamp; Mark A Neerincx; Willem-Paul Brinkman
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

3.  RC2S: A Cognitive Remediation Program to Improve Social Cognition in Schizophrenia and Related Disorders.

Authors:  Elodie Peyroux; Nicolas Franck
Journal:  Front Hum Neurosci       Date:  2014-06-13       Impact factor: 3.169

4.  How and why affective and reactive virtual agents will bring new insights on social cognitive disorders in schizophrenia? An illustration with a virtual card game paradigm.

Authors:  Ali Oker; Elise Prigent; Matthieu Courgeon; Victoria Eyharabide; Mathieu Urbach; Nadine Bazin; Michel-Ange Amorim; Christine Passerieux; Jean-Claude Martin; Eric Brunet-Gouet
Journal:  Front Hum Neurosci       Date:  2015-03-30       Impact factor: 3.169

5.  Virtual Avatar for Emotion Recognition in Patients with Schizophrenia: A Pilot Study.

Authors:  Samuel Marcos-Pablos; Emilio González-Pablos; Carlos Martín-Lorenzo; Luis A Flores; Jaime Gómez-García-Bermejo; Eduardo Zalama
Journal:  Front Hum Neurosci       Date:  2016-08-26       Impact factor: 3.169

6.  Feasibility of a virtual reality-based interactive feedback program for modifying dysfunctional communication: a preliminary study.

Authors:  Junhyung Kim; Young Hoon Jung; Yu-Bin Shin; Min-Kyeong Kim; Hyojung Eom; Eunjoo Kim; Joohan Kim; Jae-Jin Kim
Journal:  BMC Psychol       Date:  2020-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.